Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued

Published on December 23, 2024

A year after becoming available, vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, according to a new health survey.

Continue reading on website
Other news

Scientists design workaround that improves response to flu vaccine

December 19, 2024
Stitching together four molecules found in the standard flu vaccine ensures an immune response to all of them, scientists have shown.

People who are immunocompromised may not produce enough protective antibodies against RSV after vaccination

December 30, 2024
Researchers have shown that people 60 years or older with weakened immunity do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with normal immune function.